Trino
Well-Known Member
Ohioans part of promising COVID-19 vaccine research
PriMed in Dayton is recruiting 250 adults for a phase 3 clinical trial that will involve 30,000 Americans. Volunteers will receive the vaccine in two doses given a month apart, have multiple follow-up visits, blood drawn and keep a diary of their health for two years. But the study may have results before then, said Dr. William Randall, principal investigator for PriMED Clinical Research. He declined to reveal the developer of the vaccine being tested by PriMED.
Researchers at the University of Cincinnati and UC Health plan to enroll 500 patients in a study of the vaccine created by Moderna, a biotechnology company. And Ohio State Wexner Medical Center is recruiting 500 adults for a trial of a vaccine co-developed by the University of Oxford and AstraZeneca, a biopharmaceutical company.
Not to be left out Minnesotans are being recruited. HealthPartners Wednesday announced that it will be enrolling at least 1,500 people in a clinical trial that will determine whether a vaccine developed by Oxford University is effective at preventing coronavirus.
Minnesotans Can Enroll In COVID-19 Vaccine Trial